[The therapeutic results in acute myeloid leukemias in elderly patients].
Parovichnikova
E N
EN
Savchenko
V G
VG
Isaev
V G
VG
Tikhonova
L Iu
LIu
Sarycheva
T G
TG
Kulikov
S M
SM
D000208:Acute Disease; D000368:Aged; D000369:Aged, 80 and over; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects; D003561:Cytarabine / Q000008:administration & dosage / Q000009:adverse effects; D003630:Daunorubicin / Q000008:administration & dosage / Q000009:adverse effects; D004351:Drug Resistance; D005260:Female; D006801:Humans; D007951:Leukemia, Myeloid / Q000188:drug therapy* / Q000401:mortality; D008297:Male; D015122:Mercaptopurine / Q000008:administration & dosage / Q000009:adverse effects; D008875:Middle Aged; D012074:Remission Induction; D013997:Time Factors
D003561:Cytarabine; D003520:Cyclophosphamide; D015122:Mercaptopurine; D003630:Daunorubicin
Rezul'taty terapii ostrykh mieloidnykh leĭkozov u pozhilykh bol'nykh.